The West Africa ICEMR Partnerships for Guiding Policy to Improve the Malaria Prevention and Control.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
11 10 2022
Historique:
received: 23 12 2021
accepted: 06 07 2022
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

The Mali National Malaria Control Program (NMCP) recently established a phased set of goals for eliminating malaria in Mali by 2030. Over the past decade, the scale-up of NMCP-led malaria control interventions has led to considerable progress, as evidenced by multiple malariometric indicators. The West Africa International Center of Excellence in Malaria Research (WA-ICEMR) is a multidisciplinary research program that works closely with the NMCP and its partners to address critical research needs for malaria control. This coordinated effort includes assessing the effectiveness of control interventions based on key malaria research topics, including immune status, parasite genetic diversity, insecticide and drug resistance, diagnostic accuracy, malaria vector populations and biting behaviors, and vectorial capacity. Several signature accomplishments of the WA-ICEMR include identifying changing malaria age demographic profiles, testing innovative approaches to improve control strategies, and providing regular reporting on drug and insecticide resistance status. The NMCP and WA-ICEMR partnership between the WA-ICEMR and the NMCP offers a comprehensive research platform that informs the design and implementation of malaria prevention and control research programs. These efforts build local expertise and capacity for the next generation of malaria researchers and guide local policy, which is crucial in sustaining efforts toward eliminating malaria in West Africa.

Identifiants

pubmed: 36228908
doi: 10.4269/ajtmh.21-1330
pmc: PMC9662222
doi:

Substances chimiques

Insecticides 0
N-methylchlorphentermine 78558-95-9
Chlorphentermine NHW07912O7

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-89

Subventions

Organisme : FIC NIH HHS
ID : D43 TW008652
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089696
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI129387
Pays : United States
Organisme : FIC NIH HHS
ID : U2R TW010673
Pays : United States

Références

Malar J. 2009 Mar 30;8:52
pubmed: 19331684
Gates Open Res. 2019 Nov 25;3:1661
pubmed: 32047873
Acta Trop. 2012 Mar;121(3):157
pubmed: 21819955
Malar J. 2021 Aug 30;20(1):356
pubmed: 34461901
Bull Soc Pathol Exot. 2016 Feb;109(1):39-45
pubmed: 26740098
Malar J. 2020 Jan 21;19(1):33
pubmed: 31964378
Parasit Vectors. 2019 Oct 26;12(1):501
pubmed: 31655608
Malar J. 2020 Feb 14;19(1):72
pubmed: 32059671
PLoS One. 2019 Mar 28;14(3):e0214284
pubmed: 30921383
Acta Trop. 2021 Apr;216:105820
pubmed: 33400915
Malar J. 2008 Oct 10;7:205
pubmed: 18847463
Malar J. 2016 Sep 21;15(1):482
pubmed: 27655345
Malar J. 2020 Apr 6;19(1):137
pubmed: 32252774
Malar J. 2022 Feb 23;21(1):65
pubmed: 35197053
Int J Environ Res Public Health. 2020 Aug 31;17(17):
pubmed: 32878174
Lancet. 2022 Mar 26;399(10331):1202-1203
pubmed: 35339212
Malar J. 2007 Sep 06;6:120
pubmed: 17822533
Int J Environ Res Public Health. 2020 Jun 30;17(13):
pubmed: 32629876
Front Genet. 2019 Apr 12;10:331
pubmed: 31031807
Malar J. 2021 Apr 14;20(1):184
pubmed: 33853632
Health Res Policy Syst. 2020 Sep 17;18(1):105
pubmed: 32943078
Malar J. 2010 Jul 21;9:210
pubmed: 20663142
Malar J. 2017 Aug 10;16(1):325
pubmed: 28797263
Am J Trop Med Hyg. 2021 Mar 01;104(4):1342-1347
pubmed: 33646974
J Infect Dis. 2021 Apr 27;223(12 Suppl 2):S81-S90
pubmed: 33906223
Acta Trop. 2012 Mar;121(3):175-83
pubmed: 22142790
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):1-4
pubmed: 26574613
Malar J. 2020 Aug 12;19(1):286
pubmed: 32787938
Malar J. 2021 Mar 4;20(1):127
pubmed: 33663515
Malar J. 2018 Nov 14;17(1):424
pubmed: 30428880
Am J Trop Med Hyg. 2021 Nov 15;106(2):648-654
pubmed: 34781256
Bull Soc Pathol Exot. 2014 Dec;107(5):356-68
pubmed: 25326713
Drugs R D. 2020 Sep;20(3):249-255
pubmed: 32557086

Auteurs

Seydou Doumbia (S)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Mahamoudou Toure (M)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Nafomon Sogoba (N)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Michael Alifrangis (M)

Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.

Mahamadou Diakite (M)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Ayouba Diarra (A)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Moussa Keita (M)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Drissa Konaté (D)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Sory I Diawara (SI)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Sidibé M'Baye Thiam (SM)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Soumba Keita (S)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Moctar Tounkara (M)

Department of Public Health, Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Idrissa Cissé (I)

National Malaria Control Program, Ministry of Health, Bamako, Mali.

Vincent Sanogo (V)

National Malaria Control Program, Ministry of Health, Bamako, Mali.

Mahamadou H Magassa (MH)

National Malaria Control Program, Ministry of Health, Bamako, Mali.

Alyssa E Barry (AE)

School of Medicine, Deakin University, Geelong, Australia.

Peter J Winch (PJ)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Hannah C Marker (HC)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Jeffrey G Shaffer (JG)

School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.

Sékou F Traoré (SF)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Günter C Müller (GC)

Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Liwang Cui (L)

Division of Infectious Diseases and Internal Medicine, Department of Internal Medicine, University of South Florida, Tampa, Florida.

John C Beier (JC)

Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida.

Jules Mihigo (J)

U.S. President's Malaria Initiative, United States Agency for International Development Office, Bamako, Mali.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH